Nesfatin-1/NucB2, an anorexigenic molecule, is expressed mainly in the hypothalamus, 20 particularly in the supraoptic nucleus (SON) and the paraventricular nucleus (PVN). 21
Introduction
Rats were divided into control (CTR, n = 8) and PEG (n = 8) groups. Physiological saline (20 145 mL/kg body weight) or PEG (20 mL/kg body weight) was administered intraperitoneally (i.p.) as 146 described previously (23). After treatment, rats were deprived of either food or water for 6 h and 147
were then decapitated without anesthesia. Trunk blood samples were taken during decapitation. 148
Brains were immediately removed, placed on dry ice, and stored at -80°C in a deep freezer until use 149 in ISH analysis. 150 151
Nesfatin-1/NucB2 protein levels 152
Rats were divided into CTR (n = 6), 48 h WD (n = 6), and RH (n = 6) groups. After treatment, 153 rats were deeply anesthetized by intraperitoneal (i.p.) injection of sodium pentobarbital (50 mg/kg 154 body weight). Anesthetized rats were perfused transcardially, and brains were then removed and 155 stored in 4% paraformaldehyde in 0.1 M phosphate buffer (PB) at 4°C until use in IHC analysis. For i.c.v. injection of nesfatin-1/NucB2, rats were divided into two groups according to treatment 168 with vehicle (CTR, n = 6) or nesfatin-1/NucB2-neutralizing antibody (NES, n = 6). For i.c.v. 169 injection, the animals were implanted with stainless steel cannulae aimed at the lateral ventricle. The 170 animals were anesthetized with i.p. injection of sodium pentobarbital (50 mg/kg body weight) and 171 then placed in a stereotaxic frame. A stainless steel guide cannula (550 μm outer diameter, 10 mm 172 length) was implanted stereotaxically at the following coordinates: 0.8 mm posterior to the bregma, 173
1.4 mm lateral to the midline, and 2.0 mm below the surface of the left cortex such that the tip of the 174 cannula was 1.0 mm above the left cerebral ventricle. Two stainless steel anchoring screws were 175 fixed to the skull, and the cannula was secured in place by acrylic dental cement. After the surgical 176 procedure, the animals were handled for 1 week, housed individually in plastic cages, and allowed to 177 recover for at least 7 days. Thereafter, they were housed individually in metabolic cages for 2 days 178 before the start of the experiments. After being deprived of water for 48 h, a stainless steel injectorof the guide for i.c.v. injection of nesfatin-1/NucB2-neutralizing antibody (14) 
Plasma measurements 196
All rats used for plasma measurements were decapitated immediately after treatment without 197 being anesthetized. Trunk blood samples were taken during decapitation and were collected intohybridization, sections were washed four times with SSC (150 mM NaCl and 15 mM sodium citrate) 217
for 1 h at 55°C and for an additional 1 h with two changes of SSC at room temperature. Hybridized 218 sections were exposed to autoradiography film (Hyperfilm, Amersham, Bucks, UK) for 1 week. The 219 images were analyzed by computerized densitometry using an MCID imaging analyzer (Imaging 220
Research Inc., Ontario, Canada). The mean optical densities (ODs) of the autoradiographs were 221 measured by comparison with simultaneously exposed 14 C-labeled microscale samples and 222 represented in arbitrary units, with the mean OD obtained from control rats set to 100. The results 223
were blinded and analyzed randomly in duplicate by at least two researchers in order to avoid bias. 224 225
IHC for analysis of nesfatin-1/NucB2 expression 226
Rats were deeply anesthetized with i.p. injection of sodium pentobarbital (50 mg/kg body 227 weight) and were perfused transcardially with 0.1 M PB (pH 7.4) containing heparin (1000 U/L 228 saline) followed by 4% paraformaldehyde in 0.1 M PB. The brains were then removed and divided 229 into three blocks: the forebrain, hypothalamus, and brain stem. The blocks were postfixed with 4% 230 paraformaldehyde in 0.1 M PB for 48 h at 4°C. The tissues were then cryoprotected in 20% sucrose 231 in 0.1 M PB for 48 h at 4°C. Serial sections of 40 μm were cut using a microtome. The sections were 232 rinsed twice with 0.1 M phosphate-buffered saline (PBS) containing 0.3% Triton X-100 andThe sections were then rinsed twice with 0.1 M PBS containing 0.3% Triton X-100, followed by 235 incubation with anti-nesfatin-1/NucB2 antibodies (cat. No. N9414; Sigma-Aldrich Japan Co. LLC.) 236 at a dilution of 1:5000 in 0.1 M PBS containing 0.3% Triton X-100 at 4°C for 4 days. After washing 237 for 20 min in 0.1 M PBS containing 0.3% Triton X-100, the sections were incubated for 120 min 238 with a biotinylated secondary antibody solution (1:250 dilution) and finally with an avidin-biotin 239 peroxidase complex (Vectastain ABC kit; Vector Laboratories, Inc., Burlingame, CA, USA) for 120 240
min. 241
For IHC, the peroxidase in the sections was visualized by addition of 0.02% diaminobenzidine 242 in Tris buffer containing 0.05% hydrogen peroxidase for 1 min. The sections were mounted onto 243 gelatin-coated slides, air dried, dehydrated in 100% ethanol, cleared using xylene, covered by 244 coverslips, and examined under a light microscope (Nikon, Tokyo, Japan). Dark-brown staining 245 indicated nesfatin-1/NucB2-LI-positive cells. The images were analyzed by computerized 246 densitometry using Image J (NIH, MD, USA). The mean ODs of the autoradiographs were 247 determined, and values are represented in arbitrary units, with that of the control rats set at 1. Results 248 were blinded and analyzed in duplicate and bilaterally by at least two individuals in order to avoid 249
bias. 250
For fluorescence IHC, sections were incubated with primary anti-nesfatin-1/NucB2 antibodies 251 at a dilution of 1:5000 in 0.1 M PBS containing 0.3% Triton X-100 at 4°C for 4 days. After washingfor 20 min in 0.1 M PBS containing 0.3% Triton X-100, the sections were incubated with goat 253 anti-rabbit Alexa 546-labeled antibodies (Molecular Probes, Eugene, OR, USA) at room temperature 254 for 1 h. The sections were then washed twice in PBS for 10 min, mounted in glycerol/PBS (1:1) 255 solution, and covered with coverslips. Photographs were taken with a fluorescence microscope 256 (Nikon) using the appropriate excitation and emission filters. 
Results

268
Changes in nesfatin-1/NucB2 expression in the SFO, SON, and PVN after food deprivationfor 48 h. Consistent with a previous study (14), the expression of nesfatin-1/NucB2 was significantly 271 decreased after food deprivation for 48 h (SFO, 46.1 ± 10.8 %; SON, 52.9 ± 25.0 %; PVN, 59.2 ± 272 6.9 %) as compared to that in the CTR group (SFO, 100.0 ± 12.1 %; SON, 100.0 ± 13.0 %; PVN, 273 100.0 ± 15.1 %) ( Figure 1A and 1B) . 274
275
Changes in nesfatin-1/NucB2 mRNA levels in the SFO, SON, and PVN after exposure to 276
osmotic stimuli 277
Next, we evaluated weight changes, plasma measurements, and nesfatin-1/NucB2 mRNA levels 278 by ISH after exposure to osmotic stimuli. The body weights of rats in the CTR group gradually 279 increased ( Figure 2A ). In contrast, the body weights of rats in the 2% NaCl group decreased 280 significantly throughout the experiment, while those of rats in the WD group decreased significantly 281 at day 3 after the start of water deprivation (Figure 2A) . 282
The Na and P-Osm levels in rats in the 2% NaCl (Na, 177.3 ± 5.9 mEq/L; P-Osm, 334.0 ± 10.9 283 mOsm/kg) and WD (Na, 166.0 ± 1.4 mEq/L; P-Osm, 317.8 ± 3.2 mOsm/kg) groups increased 284 significantly compared to those in CTR rats (Na, 156.2 ± 0.9 mEq/L; P-Osm, 304.7 ± 2.3 mOsm/kg) 285 ( Figure 2B ). Additionally, Na levels were significantly increased in rats in the 2% NaCl group 286 compared to those in the WD group. There were no statistical differences in P-Osm levels between 287 rats in the 2% NaCl group and rats in the WD group. The TP in the 2% NaCl group (6.0 ± 0.1 g/dL)was comparable to that in the CTR group (6.3 ± 0.1 g/dL), whereas, that in the WD group (7.2 ± 0.1 289 g/dL) significantly increased compared to both the CTR and 2% NaCl groups ( Figure 2B) . 290
Next, we measured nesfatin-1/NucB2 mRNA levels at day 5 in the SFO, SON, and PVN using 291 ISH. Nesfatin-1/NucB2 mRNA signals were unclear in all examined tissues from rats in the CTR 292 group, but were clearly observed in rats in the 2% NaCl and WD groups ( Figure 2C ). Quantification 293 of nesfatin-1/NucB2 probe binding showed a dramatic increase in expression in the 2% NaCl (SFO, 294
292.3 ± 24.1 %; SON, 286.2 ± 31.1 %; PVN, 255.7 ± 31.9 %) and WD groups (SFO, 274.6 ± 295 19.5 %; SON, 264.5 ± 22.1 %; PVN, 264.7 ± 23.4 %) in all examined nuclei ( Figure 2D ). There 296 were no significant differences in probe binding between the 2% NaCl and WD groups. 297
298
Time course of changes in nesfatin-1/NucB2 mRNA levels after water deprivation 299
We then sought to investigate time-dependent changes rats following water deprivation. In the 300 12, 24, and 48h WD groups, Na levels were significantly increased (12h WD, 160.0 ± 1.5 mEq/L; 301 24h WD, 161.0 ± 1.0 mEq/L; 48h WD, 164.6 ± 1.7 mEq/L) compared to that of the CTR group 302 (155.0 ± 0.6 mEq/L), with highest levels of Na observed in the 48-h WD group ( Figure 3A ). P-Osm 303 levels were also significantly increased in the 12, 24, and 48 h WD groups (12h WD, 316.6 ± 2.2 304 mOsm/kg; 24h WD, 315.0 ± 2.6 mOsm/kg; 48h WD, 320.0 ± 5.2 mOsm/kg) ( Figure 3A ). There 305
were no significant differences in P-Osm levels between the 12-and 24-h WD groups; however, thatin the 48-h WD group was significantly increased compared to those in the 12-and 24-h WD groups 307 ( Figure 3A) . Similarly, the plasma TP in the 12, 24, and 48 h WD groups (12h WD, 6.7 ± 0.1 g/dL; 308 24h WD, 6.9 ± 0.1 g/dL; 48h WD, 7.4 ± 0.1 g/dL) was significantly increased compared to that in 309 the CTR group (6.4 ± 0.1 g/dL) ( Figure 3A) , and the TP in the 48-h group was significantly 310 increased compared to that in the 12 and 24 h WD groups ( Figure 3A ). Rehydration led to recovery 311 of all examined plasma measurements (Na, 155.3 ± 0.7 mEq/L; P-Osm, 301.8 ± 2.2 mOsm/kg; TP, 312 5.9 ± 0.1 g/dL) ( Figure 3A) . 313
The expression levels of nesfatin-1/NucB2 mRNA in the SFO, SON, and PVN were measured 314 by ISH after dehydration and rehydration. Nesfatin-1/NucB2 mRNA signals were unclear in all 315 tissues in the CTR group ( Figure 3B ). Interestingly, nesfatin-1/NucB2 mRNA expression gradually 316 increased with water deprivation in a time-dependent manner, becoming intensely expressed by 48 h 317 of water deprivation, and returned to CTR levels after 24 h of rehydration ( Figure 3B ). 318
Quantification of nesfatin-1/NucB2 probe binding showed a significant increase in all examined 319 nuclei following water deprivation in a time-dependent manner ( Figure 3C ). There were no 320 statistically significant differences among the CTR (SFO, 100.0 ± 12.4 %; SON, 100.0 ± 16.2 %; 321 PVN, 100.0 ± 12.9 %), 12 h WD (SFO, 116.6 ± 23.1 %; SON, 115.6 ± 18.0 %; PVN, 120.6 ± 9.9 %), Next, we examined the effects of PEG, which induces hypovolemia without requiring a 338 hyperosmotic state. There were no statistically significant differences between the CTR and PEG 339 groups in terms of Na (CTR, 153.0 ± 0.3 mEq/L; PEG, 156.3 ± 1.1 mEq/L) and P-Osm levels (CTR, 340 306.8 ± 1.5 mOsm/kg; PEG, 308.8 ± 4.1 mOsm/kg). However, TP and hematocrit (HCT) were 341 dramatically increased in the PEG group (TP, 5.8 ± 0.1 g/dL; HCT, 37.3 ± 0.4 %) compared to those 342 in the CTR group (TP, 7.2 ± 0.5 g/dL; HCT, 44.1 ± 1.3 %) ( Figure 5A ). Plasma nesfatin-1/NucB2 343 levels were also dramatically increased in the PEG group (1.9 ± 0.2 ng/mL) compared to the CTR 344 group (3.8 ± 0.6 ng/mL) ( Figure 5A ). Nesfatin-1/NucB2 mRNA expression was not clear in the SFO, 345 SON, and PVN in the CTR group, as measured by ISH ( Figure 5B ), however, it was clearly 346 expressed following administration of PEG ( Figure 5B ). In quantitative analysis, nesfatin-1/NucB2 347 probe binding was significantly increased in all examined nuclei following PEG administration (SFO, 348
221.1 ± 16.3 %; SON, 185.7 ± 14.5 %; PVN, 189.1 ± 11.1 %) compared to CTR (SFO, 100.0 ± 349 15.9 %; SON, 100.0 ± 14.5 %; PVN, 100.0 ± 15.4 %) ( Figure 5C ). Because the identity of nesfatin-1 receptor remains unknown to date, we used 375 nesfatin-1/NucB2-neutralizing antibodies, as previously described (14), to inhibit the development of 376 anorexia after 48 h of water deprivation. After 48 h of water deprivation,intake, urine volume, and food intake were measured for 12 h after i.c.v. injection. There were no 379 statistically significant differences between rats administered nesfatin-1/NucB2-neutralizing 380 antibodies and rats administered vehicle only in terms of cumulative water intake and urine volume 381 ( Figure 7A and 7B) . However, cumulative food intake dramatically increased immediately after 382 injection in the nesfatin-1/NucB2-neutralizing antibody group, and this effect lasted for at least 12 h 383 ( Figure 7C ). 384 385
Effects of i.c.v. administration of nesfatin-1/NucB2 after water deprivation 386
We also examined the effect of nesfatin-1/NucB2 after 48 h of water deprivation. Body weight 387
were measured daily from the start of the water deprivation. After 48 h of water deprivation, 388 nesfatin-1/NucB2 or vehicle were i.c.v. administered. Cumulative water intake, urine volume, and 389 food intake were measured for 24 h after i.c.v. injection. There were no statistically significant 390 differences between rats administered nesfatin-1/NucB2-neutralizing antibodies and rats 391 administered vehicle only in terms of cumulative water intake and urine volume ( Figure 8B and 8D) . 392
However, body weight and cumulative food intake significantly decreased after 24 h of injection in 393 the nesfatin-1/NucB2 group ( Figure 8A and 8C) .
In this study, we found that nesfatin-1/NucB2 mRNA levels were increased after exposure to 397 osmotic stimuli, such as hypertonic saline loading or water deprivation, in the SFO, SON, and PVN. 398
In addition, nesfatin-1/NucB2 levels were positively correlated with Na, P-Osm, and TP. 399
Nesfatin-1/NucB2 protein levels were also upregulated by water deprivation, but returned to control 400 levels after rehydration. Furthermore, i.c.v. injection of nesfatin-1/NucB2-neutralizing antibodies 401 after 48 h of water deprivation allowed the recovery of food intake levels. These results suggested 402 that nesfatin-1/NucB2 has important roles in maintaining body fluid homeostasis and 403 dehydration-induced anorexia. 404
Drinking hypertonic saline instead of tap water or water deprivation for 48 h resulted in a 405 significant decrease in body weight, consistent with a previous report (24). Additionally, as expected, 406
Na and P-Osm significantly increased in the 2% NaCl and WD groups. Because P-Osm levels are 407 defined by plasma glucose, blood urea nitrogen, and plasma Na levels (3), Na and P-Osm may 408 change simultaneously. Moreover, we previously measured TP as an indicator of hypovolemia (23) 409 and found that the TP levels in rats consuming 2% NaCl were comparable to that of rats in the CTR 410 group, indicating that drinking hypertonic saline does not cause hypovolemia in rats. 411
Expression of the nesfatin-1/NucB2 gene was observed in the SFO, SON, and PVN by ISH 412 analysis. As these three tissues are involved in body fluid regulation, our obtained data indicated thatStrong nesfatin-1/NucB2 mRNA expression, about 2.5-to 3-folds, in the SFO, SON, and PVN was 415 
carefully. 426
If body fluid volume is insufficient, organisms will generally try to maintain body fluid balance 427 by increasing plasma osmolality or plasma sodium concentration; however, when the body fluid 428 volume continues to decrease, it results in the development of hypovolemia. In our study, we 429 observed that TP gradually increased following water deprivation in a time-dependent manner, whilesevere dehydration and hypovolemia. 433
Similar to the observed changes in TP, we also found that nesfatin-1/NucB2 mRNA signals in 434 the SFO, SON, and PVN gradually increased with longer water deprivation times, indicating the 435 occurrence of hypovolemia. Thus, nesfatin-1/NucB2, Na, and P-Osm may all be involved in 436 mediating the occurrence of hypovolemia. However, our data suggested that upregulation of 437 nesfatin-1/NucB2 may be more involved than osmotic changes since TP had the strongest positive 438 correlation with nesfatin-1/NucB2 mRNA levels in all examined tissues. To further test this 439 hypothesis, we used PEG, which induces hypovolemia without requiring a hyperosmotic state (23). 440
Measurement of plasma parameters following PEG administration suggested the development of 441
hypovolemia instead of hyperosmolality, and nesfatin-1/NucB2 gene expression dramatically 442 increased after PEG administration in all examined nuclei. These results were consistent with our 443 correlation study. Moreover, we also measured plasma nesfatin-1/NucB2 by ELISA and found 444 significantly increased expression following PEG administration. Thus, our results suggested that 445 nesfatin-1/NucB2 levels were upregulated in the peripheral and central nervous systems. 446 Hyperosmolemia appears to be the principal signal for dehydration-induced anorexia, and there 447 is a strong correlation between plasma osmolality and the suppression of food intake (26). Our 448 results revealed that nesfatin-1/NucB2 gene expression and nesfatin-1/NucB2 protein levels werenesfatin-1/NucB2 is a satiety molecule, we hypothesized that nesfatin-1/NucB2 causes 451 dehydration-induced anorexia and that water intake and urine volume may be altered following i.c.v. 452 injection of nesfatin-1/NucB2-neutralizing antibodies; however, this was not the case. In contrast, 453
Yosten et al. reported that i.c.v. administration of nesfatin-1/NucB2 results in lower consumption of 454 water than that of control animals after 18 h of fluid restriction (29-31). However, because our 455 studies were performed after 48 h of water deprivation, leading to the development of severe 456 hypovolemia and hyperosmolality, the results of our study cannot be compared directly with the 457 results of these previous works. One of the reasons that we may not have observed exaggerated fluid 458 intake in nesfatin-1/NucB2-neutralizing antibody-treated animals compared to vehicle-treated 459 animals is that the effects of fluid deprivation may be overpowering, preventing us from observing 460 changes in fluid intake with nesfatin-1 neutralization. We did not observe that rats consumed less 461 water than controls after administration of nesfatin-1/NucB2-neutralizing antibodies following 12 or 462 24 h of water deprivation. Nevertheless, further studies are required to elucidate the mechanisms 463 underlying these observations. 464
In our study, i.c.v. injection of nesfatin-1/NucB2-neutralizing antibodies dramatically increased 465 food intake despite water deprivation. It has been hypothesized that dehydration primarily causes 466 upregulation of anorexigenic neuropeptides in the hypothalamus, leading to upregulation of the 467 expression of orexigenic neuropeptides by anorexia-induced starvation (21). and PVN, triggering the organism to feel thirsty (consuming more water, less food) and thereby 488 preventing an increase in osmolality. While our data do not definitively answer the question as to 489 whether nesfatin-1/nucB2 is a critical factor in dehydration-induced anorexia, we can conclude that 490 nesfatin-1/NucB2 may be involved in dehydration-induced anorexia, functioning to maintain 491 whole-organism homeostasis in animals. 492
In conclusion, we showed that nesfatin-1/NucB2 may have important roles in maintaining body 493 fluid homeostasis or in mediating dehydration-induced anorexia. Nesfatin-1/NucB2 may also act as a 494 regulatory factor, functioning to maintain body Na concentrations. Thus, our study provides 495 important insights into the elucidation of physiological functions regulating body fluid homeostasis, 496 a process related to feeding and drinking behaviors. CTR, n = 6; 2% NaCl, n = 7; WD, n = 6. 643 (B) Plasma measurements after decapitation at day 5. *P < 0.05 vs. CTR; **P < 0.01 vs. CTR; # P < 644 0.05 vs. 2% NaCl;
## P < 0.01 vs. all other experimental groups. Data are presented as means ± SEMs. 645 CTR, n = 6; 2% NaCl, n = 7; WD, n = 6. 
